Patient HLA-DP-Specific CD4+ T Cells from HLA-DPB1-Mismatched Donor Lymphocyte Infusion Can Induce Graft-versus-Leukemia Reactivity in the Presence or Absence of Graft-versus-Host Disease

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 1, 2013, Pages 40-48

  Rutten, Caroline E ^a   van Luxemburg Heijs, Simone A P ^a   Halkes, Constantijn J M ^a   van Bergen, Cornelis A M ^a   Marijt, Erik W A ^a   Oudshoorn, Machteld ^a,b   Griffioen, Marieke ^a   Falkenburg, J H Frederik ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Europdonor Foundation   (Netherlands)

Author keywords

Alloreactivity; Hematopoietic stem cell transplantation; HLA class II mismatch; T cell

Indexed keywords

CD137 ANTIGEN; HLA DP ANTIGEN; HLA DPB1 ANTIGEN;

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; B CELL LYMPHOMA; BASE MISPAIRING; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR LYMPHOCYTE INFUSION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HLA SYSTEM; HUMAN; MULTIPLE MYELOMA; MYELOID LEUKEMIA; RECURRENCE RISK; T CELL DEPLETION; TREATMENT RESPONSE;

ANTIGENS, CD137; CD4-POSITIVE T-LYMPHOCYTES; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOLOGIC NEOPLASMS; HLA-DP BETA-CHAINS; HUMANS; MALE; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; UNRELATED DONORS;

EID: 84871920705     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.07.020     Document Type: Article

References (33)

1. Collins R.H., Shpilberg O., Drobyski W.R., et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997, 15:433-444.
2. Kolb H.J., Schattenberg A., Goldman J.M., et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995, 86:2041-2050.
3. Kolb H.J. Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 2008, 112:4371-4383.
4. Marijt W.A., Heemskerk M.H., Kloosterboer F.M., et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 2003, 100:2742-2747.
5. Rutten C.E., van Luxemburg-Heijs S.A., Griffioen M., et al. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia. Leukemia 2008, 22:1387-1394.
6. van Bergen C.A., Rutten C.E., van der Meijden E.D., et al. High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning. Cancer Res 2010, 70:9073-9083.
7. Flomenberg N., Baxter-Lowe L.A., Confer D., et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004, 104:1923-1930.
8. Lee S.J., Klein J., Haagenson M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110:4576-4583.
9. Loiseau P., Busson M., Balere M.L., et al. HLA association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival. Biol Blood Marrow Transplant 2007, 13:965-974.
10. Kawase T., Matsuo K., Kashiwase K., et al. HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism. Blood 2009, 113:2851-2858.
11. Shaw B.E., Marsh S.G., Mayor N.P., et al. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood 2006, 107:1220-1226.
12. Shaw B.E., Gooley T.A., Malkki M., et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood 2007, 110:4560-4566.
13. Shaw B.E., Mayor N.P., Russell N.H., et al. Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia 2010, 24:58-65.
14. Gaschet J., Lim A., Liem L., et al. Acute graft-versus-host disease due to T lymphocytes recognizing a single HLA-DPB1 0501 mismatch. J Clin Invest 1996, 98:100-107.
15. Gaschet J., Gallot G., Ibisch C., et al. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1 1001 mismatch: involvement of different TCRBV subsets. Bone Marrow Transplant 1998, 22:385-392.
16. Shaw B.E., Potter M.N., Mayor N.P., et al. The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation. Bone Marrow Transplant 2003, 31:1001-1008.
17. Ibisch C., Gallot G., Vivien R., et al. Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation. Bone Marrow Transplant 1999, 23:1153-1159.
18. + T cell responses showing immunogenicity of all HLA-DPB1 alleles. Biol Blood Marrow Transplant 2010, 16:1282-1292.
19. Crocchiolo R., Zino E., Vago L., et al. Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. Blood 2009, 114:1437-1444.
20. Wehler T.C., Karg M., Distler E., et al. Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression. J Immunol Methods 2008, 339:23-37.
21. Zandvliet M.L., van Liempt E., Jedema I., et al. Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation. J Immunother 2011, 34:307-319.
22. Zino E., Frumento G., Marktel S., et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood 2004, 103:1417-1424.
23. Sherman L.A., Chattopadhyay S. The molecular basis of allorecognition. Annu Rev Immunol 1993, 11:385-402.
24. Griffioen M., van der Meijden E.D., Slager E.H., et al. Identification of phosphatidylinositol 4-kinase type II beta as a HLA class II-restricted target in graft versus leukemia reactivity. Proc Natl Acad Sci USA 2008, 105:3837-3842.
25. Stumpf A.N., van der Meijden E.D., van Bergen C.A., et al. Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity. Blood 2009, 114:3684-3692.
26. Vogt M.H., Van Den Muijsenberg J.W., Goulmy E., et al. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood 2002, 99:3027-3032.
27. Zorn E., Miklos D.B., Floyd B.H., et al. Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. J Exp Med 2004, 199:1133-1142.
28. + T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemia. Leukemia 2012, 26:312-322.
29. Holloway P.A., Kaldenhoven N., Kok-Schoemaker H.M., et al. A class II-restricted cytotoxic T-cell clone recognizes a human minor histo-compatibility antigen with a restricted tissue distribution. Br J Haematol 2005, 128:73-81.
30. + cytotoxic human T lymphocytes directed at a single minor histocompatibility antigen. Clin Cancer Res 2010, 16:5481-5488.
31. Slager E.H., Honders M.W., Van Der Meijden E.D., et al. Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer. Blood 2006, 107:4954-4960.
32. van Bergen C.A., Kester M.G., Jedema I., et al. Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene. Blood 2007, 109:4089-4096.
33. Michalek J., Collins R.H., Hill B.J., et al. Identification and monitoring of graft-versus-host-specific T-cell clone in stem cell transplantation. Lancet 2003, 361:1183-1185.